Effect of ciclesonide and fluticasone on hypothalamicpituitary-adrenal axis function in adults with mild-to-moderate persistent asthma

These findings confirm the safety of ciclesonide therapy, demonstrating that at doses up to 640 μg/d, the drug does not affect sensitive markers of adrenal function.